0001062993-22-008073.txt : 20220317
0001062993-22-008073.hdr.sgml : 20220317
20220317173308
ACCESSION NUMBER: 0001062993-22-008073
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220315
FILED AS OF DATE: 20220317
DATE AS OF CHANGE: 20220317
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ENLOE J DAVID JR
CENTRAL INDEX KEY: 0001201526
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36329
FILM NUMBER: 22750037
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Recro Pharma, Inc.
CENTRAL INDEX KEY: 0001588972
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 261523233
STATE OF INCORPORATION: PA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
BUSINESS PHONE: 770-534-8239
MAIL ADDRESS:
STREET 1: 1 E. UWCHLAN AVE, SUITE 112
CITY: EXTON
STATE: PA
ZIP: 19341
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0306
4
2022-03-15
0001588972
Recro Pharma, Inc.
REPH
0001201526
ENLOE J DAVID JR
C/O RECRO PHARMA, INC.
1 E. UWCHLAN AVE, SUITE 112
EXTON
PA
19341
1
1
0
0
Chief Executive Officer
Common Stock
2022-03-15
4
P
0
512
1.96
A
524879
D
This transaction was effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person.
Ryan D Lake, attorney-in-fact
2022-03-17